Prehabilitation and heart failure: main outcomes in the COVID-19 era.
Eur Rev Med Pharmacol Sci
; 26(11): 4131-4139, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-1904141
ABSTRACT
OBJECTIVE:
The advent of the SARS-CoV-2 pandemic has resulted in an increase in sedentary behavior, with consequences on cardiopulmonary capacity, especially in the elderly population. Prehabilitation is a strategy usually used before a surgical procedure to improve functional capacity; however, it can be used for non-surgical patients and not in the acute phase of disease. The purpose of this study is to evaluate the effectiveness of a prehabilitation program, using telerehabilitation, in frail elderly patients with chronic heart failure. PATIENTS ANDMETHODS:
This is a randomized, controlled, single-blind study. Fifteen patients with chronic heart failure were randomized into three groups two active groups (telerehabilitation and in-person) and the control group. Patients in the active groups underwent a rehabilitation program divided into two 4-week periods, for 45-60 minutes per day, 2 days per week.RESULTS:
In the Study Group, the quality of life significantly improved (EQoL-5D), and between the two groups a statistically significant difference in the motor dimension of SF-36 was identified.CONCLUSIONS:
The telerehabilitation prehabilitation program for patients with chronic heart failure was confirmed to be effective and not inferior to a prehabilitation program performed in-person, avoiding the worsening of some domains of quality of life and motor performance, and leading to the improvement of others.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Heart Failure
Type of study:
Experimental Studies
/
Randomized controlled trials
Limits:
Aged
/
Humans
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2022
Document Type:
Article
Affiliation country:
Eurrev_202206_28986
Similar
MEDLINE
...
LILACS
LIS